Paratek Pharmaceuticals, Inc

(NASDAQ:PRTK)

Latest On Paratek Pharmaceuticals, Inc (PRTK):

Date/Time Type Description Signal Details
2023-05-10 06:23 ESTNewsParatek Pharmaceuticals, Inc. 2023 Q1 - Results - Earnings Call PresentationN/A
2023-05-10 06:23 ESTNewsParatek Pharmaceuticals, Inc. (PRTK) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 17:20 ESTNewsParatek Pharmaceuticals GAAP EPS of -$0.35 beats by $0.03, revenue of $31.24M misses by $0.39MN/A
2023-05-09 03:27 ESTNewsParatek Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-05-02 13:32 ESTNewsParatek a new buy at Jefferies on growing antibiotics businessN/A
2023-03-30 10:34 ESTNewsParatek Pharmaceuticals shares purchased by Highland Capital ManagementN/A
2023-03-22 00:24 ESTNewsParatek Pharmaceuticals up 20% on takeout speculation - reportN/A
2023-03-16 22:20 ESTNewsParatek stock slumps ~25% despite Q4 revenue beat as FY23 sales outlook below estimatesN/A
2023-03-16 22:19 ESTNewsParatek Pharmaceuticals, Inc. (PRTK) Q4 2022 Earnings Call TranscriptN/A
2023-03-16 22:19 ESTNewsParatek Pharmaceuticals GAAP EPS of -$0.13 misses by $0.23, revenue of $75.6M beats by $12.13MN/A
2023-03-15 15:43 ESTNewsParatek Pharmaceuticals FY 2022 Earnings PreviewN/A
2023-01-18 10:31 ESTNewsParatek/ Zai Lab antibiotic added for reimbursement in ChinaN/A
2022-12-19 23:30 ESTNewsParatek's treatment for pulmonary anthrax shows promise in studyN/A
2022-11-04 07:16 ESTNewsParatek Pharmaceuticals GAAP EPS of -$0.38, revenue of $30.2MN/A
2022-11-04 07:15 ESTNewsParatek Pharmaceuticals, Inc. (PRTK) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 22:08 ESTNewsParatek Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-08-25 01:12 ESTNewsParatek Pharmaceuticals: Patience Is Wearing ThinN/A
2022-08-04 15:41 ESTNewsParatek Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-04 00:57 ESTNewsParatek Pharmaceuticals GAAP EPS of -$0.33 beats by $0.01, revenue of $29.6M beats by $0.42MN/A
2022-08-04 00:56 ESTNewsParatek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-02 19:54 ESTNewsParatek Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-22 06:47 ESTNewsParatek Pharmaceuticals stock soars postmarket on fast track designation for NuzyraN/A
2022-05-05 08:14 ESTNewsParatek Pharmaceuticals GAAP EPS of -$0.35 in-line, revenue of $24.86M misses by $2.29MN/A
2022-05-05 08:13 ESTNewsParatek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 08:13 ESTNewsParatek Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-03 19:27 ESTNewsParatek Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-03-14 15:31 ESTNewsParatek Pharmaceuticals GAAP EPS of -$1.22 misses by $0.31, revenue of $130.16M misses by $3.57MN/A
2022-03-14 15:31 ESTNewsParatek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-03 08:30 ESTNewsParatek Pharmaceuticals: A Deeply Undervalued Antibiotic CompanyN/A
2021-12-16 12:24 ESTNewsParatek, Zai Labs up on Chinese approval of Nuzyra for pneumonia, skin infectionsN/A
2021-11-09 15:13 ESTNewsParatek Pharmaceuticals, Inc. (PRTK) CEO Evan Loh on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 17:24 ESTNewsWarning: PRTK is at high risk of performing badlyN/A
2021-11-08 17:23 ESTNewsParatek Pharmaceuticals EPS beats by $0.08, beats on revenueN/A
2021-11-08 17:23 ESTNewsParatek Pharmaceuticals rises 6% after Q3 2021 earnings beatN/A
2021-11-07 21:02 ESTNewsParatek Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-18 19:37 ESTNewsThe Play On Paratek PharmaceuticalsN/A
2021-10-18 19:37 ESTNewsParatek rises 4% amid enrollment of patient in phase 2b trial of bacterial lung diseaseN/A
2021-09-28 00:08 ESTNewsParatek gets additional BARDA funding for the development of NuzyraN/A
2021-09-24 11:40 ESTNewsPRTK, AGIO, GASS and CAMP among after hours moversN/A
2021-08-19 12:25 ESTNewsParatek nabs FDA orphan drug designation for NUZYRA for pulmonary diseaseN/A
2021-08-13 19:22 ESTNewsParatek Pharmaceuticals (PRTK) Investor Presentation - SlideshowN/A
2021-08-10 10:14 ESTNewsParatek Pharmaceuticals EPS misses by $0.12, misses on revenueN/A
2021-08-10 10:13 ESTNewsParatek Pharmaceuticals' (PRTK) CEO Evan Loh on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-07 05:25 ESTNewsPeeking Back In On Paratek PharmaceuticalsN/A
2021-08-05 11:44 ESTNewsParatek shares rise after CDC adds NUZYRA to plague guidelinesN/A
2021-07-21 20:35 ESTNewsParatek shares rise after FDA approves NUZYRA oral only dosing regimenN/A
2021-07-21 20:21 ESTNewsParatek Pharma launches Phase 2b Nuzyra study in nontuberculous mycobacterialN/A
2021-07-21 20:15 ESTNewsParatek and ResMed price targets raised, Orphazyme downgraded; in today’s analyst actionN/A
2021-07-21 20:08 ESTNewsParatek delivers first procurement of NUZYRA to BARDAN/A
2021-04-27 23:00 ESTNewsParatek Offers Long-Term Value Potential In The Difficult Antibiotic BusinessN/A

About Paratek Pharmaceuticals, Inc (PRTK):

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a tetracycline designed for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and cooperative research and development agreement with the U.S. Army Medical Research Institute of Infectious Diseases to study omadacycline against pathogenic agents causing infectious diseases. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.

PRTK Quotes by TradingView

See Advanced Chart

General

  • Name Paratek Pharmaceuticals, Inc
  • Symbol PRTK
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Last Split Factor1:12
  • Last Split Date2014-10-31
  • Fiscal Year EndDecember
  • IPO Date2006-05-11
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://paratekpharma.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 7.37
  • Enterprise Value Revenue 4.95
  • Enterprise Value EBITDA 0.38
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.24
  • Next Year EPS Estimate -$0.11
  • Next Quarter EPS Estimate -$0.14
  • Profit Margin -206%
  • Operating Margin -161%
  • Return on Assets -22%
  • Revenue 46.92 million
  • Earnings Per Share -$3.85
  • Revenue Per Share $1.06
  • Gross Profit 14.35 million
  • Quarterly Earnings Growth 78.6%
View More

Highlights

  • Market Capitalization 367.87 million
  • PEG Ratio -0.02
  • Analyst Target Price $20.5
  • Book Value Per Share -$0.42
View More

Share Statistics

  • Shares Outstanding 45.64 million
  • Shares Float 39.3 million
  • % Held by Insiders 904%
  • % Held by Institutions 52.65%
  • Shares Short 4.47 million
  • Shares Short Prior Month 4.4 million
  • Short Ratio 8.5
  • Short % of Float 10%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.54
  • 52 Week High $8.75
  • 52 Week Low $2.65
  • 50 Day Moving Average 7.48
  • 200 Day Moving Average 6.29
View More

Dividends

  • Dividend Date 2014-10-29
  • ExDividend Date 2014-10-31
  • Dividend Yield 0%
View More

Paratek Pharmaceuticals, Inc (PRTK) Dividend Calendar:

PRTK's last dividend payment was made to shareholders on October 29, 2014.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Paratek Pharmaceuticals, Inc (PRTK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-24$N/A-$0.49-$0.24-108.37%
2020-09-302020-11-05$N/A-$0.46-$0.6326.98%
2020-06-302020-08-10$N/A-$0.53-$0.17-217.94%
2020-03-312020-05-11$7.92 million-$0.66-$0.7815.38%
2019-12-312020-02-25$8.97 million-$0.81-$0.9716.06%
2019-09-302019-11-12$3.93 million-$1.00-$1.043.85%
2019-06-302019-08-06$2.05 million-$1.02-$1.1612.07%
2019-03-312019-05-08$1.6 million-$1.10-$1.186.94%
2018-12-312019-02-27$17.02 million-$0.71-$0.59-20.85%
2018-09-302018-11-06$50000-$1.01-$0.85-18.87%
2018-06-302018-08-02$40000-$0.94-$0.93-1.23%
2018-03-312018-05-09$10000-$0.91-$0.91-0.19%
2017-12-312018-03-01$5.07 million-$0.78-$0.75-4.85%
2017-09-302017-11-08$12000-$0.77-$0.9619.67%
2017-06-302017-08-02$7.51 million-$0.65-$0.9833.42%
2017-03-312017-05-04$18000-$1.14-$1.226.3%
2016-12-312017-03-02$29000-$1.12-$1.3315.79%
2016-09-302016-11-02$N/A-$1.04-$1.3724.01%
2016-06-302016-08-04$N/A-$1.69-$1.66-1.61%
2016-03-312016-05-02$N/A-$1.78-$1.25-42.17%
2015-12-312016-02-23$N/A-$1.20-$1.296.61%
2015-09-302015-11-12$N/A-$1.33-$0.94-41.49%
2015-06-302015-08-05$N/A-$0.96-$0.75-28%
2015-03-312015-04-02$N/A-$0.74-$0.35-111.43%
2014-09-302014-10-28$-112000-$5.14
2014-06-302014-08-06$294000-$2.16-$2.285.26%
2014-03-312014-05-05$48000-$1.80-$2.1616.67%
2013-12-312014-03-13$478000-$3.48-$2.52-38.1%
2013-09-302013-11-07$184000-$3.00-$2.35-27.66%
2013-06-302013-08-07$6.03 million-$2.40-$4.0240.3%
2013-03-312013-05-08$-5830000-$6.72-$4.26-57.75%
2012-12-312013-02-27$9.6 million-$4.20-$3.34-25.75%
2012-09-302012-11-12$-2821000$3.00$0.77289.61%
2012-06-302012-08-13$2.82 million-$3.60-$2.83-27.21%
2012-03-312012-05-14$N/A-$4.44-$6.4431.06%
2011-12-312012-03-14$43.14 million$4.44-$2.04317.65%
2011-09-302011-11-10$-10154000-$4.44-$3.90-13.85%
2011-06-302011-08-11$10.15 million-$2.04-$3.1835.85%
2011-03-312011-05-16$N/A-$1.68-$3.1847.17%
2010-12-312011-03-16$25.77 million-$2.40-$3.3628.57%
2010-09-302010-11-11$N/A-$2.52-$2.582.33%
2010-06-302010-08-09$N/A-$1.80-$1.800%
2010-03-312010-05-12$N/A-$1.68-$1.9815.15%
2009-12-312010-03-23-$2.16-$2.8223.4%
2009-09-302009-11-12-$3.48$2.64-231.82%
2009-06-302009-08-14-$6.48-$6.966.9%
2009-03-312009-05-14-$11.38
2008-12-312009-03-24-$115.75
2008-09-302008-11-11-$85.44
2008-06-302008-08-11$21.84$23.28-6.19%
2008-03-312008-05-12-$0.60-$3.3081.82%
2007-12-312008-03-17-$1.20-$0.04-2900%
2007-09-302007-11-12-$1.56-$3.8159.06%
2007-06-302007-08-14-$8.28-$4.95-67.27%
2007-03-312007-05-14-$5.52-$5.34-3.37%
2006-12-312007-03-26-$4.08-$4.448.11%
2006-09-302006-11-13-$3.60-$5.3232.33%
2006-06-302006-08-10-$7.20-$5.56-29.5%

Paratek Pharmaceuticals, Inc (PRTK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Paratek Pharmaceuticals, Inc (PRTK) Chart:

Paratek Pharmaceuticals, Inc (PRTK) News:

Below you will find a list of latest news for Paratek Pharmaceuticals, Inc (PRTK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Paratek Pharmaceuticals, Inc (PRTK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest PRTK Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST74$2.035
Jun 13, 2022 7:59 PM EST24$2.035
Jun 13, 2022 7:59 PM EST5$2.04
Jun 13, 2022 7:59 PM EST34$2.035
Jun 13, 2022 7:59 PM EST26$2.035

Paratek Pharmaceuticals, Inc (PRTK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-19S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1178711/000119312520174061/0001193125-20-174061-index.htm
2020-05-22UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1178711/000000000020004630/0000000000-20-004630-index.htm
2019-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000021545719004762/0000215457-19-004762-index.htm
2020-02-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000083423720005789/0000834237-20-005789-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000090266419001086/0000902664-19-001086-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000090266420001050/0000902664-20-001050-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000642/0000904454-18-000642-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000644/0000904454-18-000644-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000646/0000904454-18-000646-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000648/0000904454-18-000648-index.htm
2018-10-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000650/0000904454-18-000650-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000661/0000904454-18-000661-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000663/0000904454-18-000663-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000665/0000904454-18-000665-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000667/0000904454-18-000667-index.htm
2018-10-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000669/0000904454-18-000669-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000781/0000904454-18-000781-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000783/0000904454-18-000783-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000785/0000904454-18-000785-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000787/0000904454-18-000787-index.htm
2018-12-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000789/0000904454-18-000789-index.htm
2018-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445418000798/0000904454-18-000798-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000147/0000904454-19-000147-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000149/0000904454-19-000149-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000151/0000904454-19-000151-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000153/0000904454-19-000153-index.htm
2019-02-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000155/0000904454-19-000155-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000178/0000904454-19-000178-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000180/0000904454-19-000180-index.htm
2019-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000182/0000904454-19-000182-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000256/0000904454-19-000256-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000258/0000904454-19-000258-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000260/0000904454-19-000260-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000272/0000904454-19-000272-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000274/0000904454-19-000274-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000276/0000904454-19-000276-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000278/0000904454-19-000278-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000280/0000904454-19-000280-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000282/0000904454-19-000282-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000284/0000904454-19-000284-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000287/0000904454-19-000287-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000289/0000904454-19-000289-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000291/0000904454-19-000291-index.htm
2019-02-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000293/0000904454-19-000293-index.htm
2019-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000351/0000904454-19-000351-index.htm
2019-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000649/0000904454-19-000649-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000667/0000904454-19-000667-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000669/0000904454-19-000669-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000672/0000904454-19-000672-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000674/0000904454-19-000674-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000676/0000904454-19-000676-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000678/0000904454-19-000678-index.htm
2019-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000680/0000904454-19-000680-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000739/0000904454-19-000739-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000741/0000904454-19-000741-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000743/0000904454-19-000743-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445419000745/0000904454-19-000745-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000224/0000904454-20-000224-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000226/0000904454-20-000226-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000228/0000904454-20-000228-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000230/0000904454-20-000230-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000232/0000904454-20-000232-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000234/0000904454-20-000234-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000236/0000904454-20-000236-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000238/0000904454-20-000238-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000240/0000904454-20-000240-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000242/0000904454-20-000242-index.htm
2020-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000244/0000904454-20-000244-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000357/0000904454-20-000357-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000359/0000904454-20-000359-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000361/0000904454-20-000361-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000363/0000904454-20-000363-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000365/0000904454-20-000365-index.htm
2020-11-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1178711/000090445420000693/0000904454-20-000693-index.htm
2018-11-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000091957418007121/0000919574-18-007121-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000091957419001724/0000919574-19-001724-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000091957420001647/0000919574-20-001647-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000119312519040736/0001193125-19-040736-index.htm
2019-02-15SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000119312519042464/0001193125-19-042464-index.htm
2019-07-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1178711/000119312519188365/0001193125-19-188365-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000119312520030571/0001193125-20-030571-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000119312520038528/0001193125-20-038528-index.htm
2020-05-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1178711/000119312520138264/0001193125-20-138264-index.htm
2020-06-19S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1178711/000119312520174061/0001193125-20-174061-index.htm
2020-06-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1178711/000119312520174086/0001193125-20-174086-index.htm
2018-08-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459018018613/0001564590-18-018613-index.htm
2018-08-02S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1178711/000156459018018615/0001564590-18-018615-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459018020357/0001564590-18-020357-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459018023851/0001564590-18-023851-index.htm
2018-10-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459018023972/0001564590-18-023972-index.htm
2018-10-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459018024468/0001564590-18-024468-index.htm
2018-10-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459018024732/0001564590-18-024732-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459018027389/0001564590-18-027389-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459018027395/0001564590-18-027395-index.htm
2018-11-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1178711/000156459018027534/0001564590-18-027534-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459018030415/0001564590-18-030415-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019000204/0001564590-19-000204-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019004708/0001564590-19-004708-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019004947/0001564590-19-004947-index.htm
2019-03-0610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1178711/000156459019006315/0001564590-19-006315-index.htm
2019-03-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1178711/000156459019006490/0001564590-19-006490-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019008126/0001564590-19-008126-index.htm
2019-04-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1178711/000156459019013354/0001564590-19-013354-index.htm
2019-04-26DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1178711/000156459019013355/0001564590-19-013355-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459019017306/0001564590-19-017306-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019022345/0001564590-19-022345-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019023545/0001564590-19-023545-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019024440/0001564590-19-024440-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459019029353/0001564590-19-029353-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459019042902/0001564590-19-042902-index.htm
2019-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459019046331/0001564590-19-046331-index.htm
2020-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459020006381/0001564590-20-006381-index.htm
2020-03-1010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1178711/000156459020009802/0001564590-20-009802-index.htm
2020-03-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1178711/000156459020010054/0001564590-20-010054-index.htm
2020-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1178711/000156459020018483/0001564590-20-018483-index.htm
2020-04-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1178711/000156459020018490/0001564590-20-018490-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459020023825/0001564590-20-023825-index.htm
2020-05-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1178711/000156459020027465/0001564590-20-027465-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1178711/000156459020029195/0001564590-20-029195-index.htm
2020-07-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1178711/000156459020031907/0001564590-20-031907-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459020038591/0001564590-20-038591-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1178711/000156459020051367/0001564590-20-051367-index.htm
2019-12-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1178711/000156761919022775/0001567619-19-022775-index.htm
2020-07-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1178711/999999999520001735/9999999995-20-001735-index.htm
2018-08-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1178711/999999999718007346/9999999997-18-007346-index.htm
2019-03-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1178711/999999999719001271/9999999997-19-001271-index.htm

Paratek Pharmaceuticals, Inc (PRTK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Paratek Pharmaceuticals, Inc (PRTK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 904%
Institutional Ownership: 5265%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-04-05Douglas W. PaganChief Financial OfficerBuy30,000.00100,807.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000351/0000904454-19-000351-index.htm
2019-02-15Jeffrey SteinDirectorSell3,375.007.1424,097.5010,125.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000256/0000904454-19-000256-index.htm
2018-10-15William M. HaskelSr. VP, Sec. & General CounselSell2,231.008.9619,989.76102,683.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000665/0000904454-18-000665-index.htm
2019-10-04Randall B. BrennerChief Development & RegulatoryBuy12,000.00103,338.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000674/0000904454-19-000674-index.htm
2018-10-02William M. HaskelSr. VP, Sec. & General CounselBuy25,000.00104,774.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000650/0000904454-18-000650-index.htm
2018-10-12William M. HaskelSr. VP, Sec. & General CounselBuy6,000.00104,914.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000665/0000904454-18-000665-index.htm
2019-02-05William M. HaskelSr. VP, Sec. & General CounselSell1,331.006.779,010.87112,220.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000178/0000904454-19-000178-index.htm
2018-10-02Adam WoodrowVP & Chief Commercial OfficerBuy23,750.00112,917.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000646/0000904454-18-000646-index.htm
2019-02-01William M. HaskelSr. VP, Sec. & General CounselBuy15,000.00113,551.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000155/0000904454-19-000155-index.htm
2019-04-05Douglas W. PaganChief Financial OfficerSell37,000.00114,557.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000351/0000904454-19-000351-index.htm
2018-10-03Douglas W. PaganChief Financial OfficerSell7,579.009.8274,425.78119,504.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000644/0000904454-18-000644-index.htm
2019-02-26Thomas John DietzDirectorBuy7,500.0012,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000274/0000904454-19-000274-index.htm
2018-12-12Douglas W. PaganChief Financial OfficerSell2,918.006.7619,725.68120,302.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000787/0000904454-18-000787-index.htm
2018-10-15Douglas W. PaganChief Financial OfficerSell2,784.008.9624,944.64123,220.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000667/0000904454-18-000667-index.htm
2018-10-12Douglas W. PaganChief Financial OfficerBuy6,500.00126,004.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000667/0000904454-18-000667-index.htm
2018-10-02Douglas W. PaganChief Financial OfficerBuy27,500.00127,083.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000644/0000904454-18-000644-index.htm
2020-05-12Randall B. BrennerChief Development & RegulatorySell6,198.004.7529,440.50130,813.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000363/0000904454-20-000363-index.htm
2018-10-03Adam WoodrowVP & Chief Commercial OfficerSell8,750.009.8285,925.00131,667.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000646/0000904454-18-000646-index.htm
2018-12-12Adam WoodrowVP & Chief Commercial OfficerSell3,733.006.7625,235.08131,775.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000781/0000904454-18-000781-index.htm
2019-02-05Douglas W. PaganChief Financial OfficerSell2,495.006.7716,891.15134,057.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000180/0000904454-19-000180-index.htm
2018-10-15Adam WoodrowVP & Chief Commercial OfficerSell2,659.008.9623,824.64135,508.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000661/0000904454-18-000661-index.htm
2019-02-01Douglas W. PaganChief Financial OfficerBuy16,250.00136,552.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000151/0000904454-19-000151-index.htm
2020-02-19Randall B. BrennerChief Development & RegulatoryBuy45,000.00137,011.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000228/0000904454-20-000228-index.htm
2018-10-12Adam WoodrowVP & Chief Commercial OfficerBuy6,500.00138,167.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000661/0000904454-18-000661-index.htm
2018-10-02Adam WoodrowVP & Chief Commercial OfficerBuy27,500.00140,417.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000646/0000904454-18-000646-index.htm
2019-02-26Robert S RadieDirectorBuy7,500.0014,250.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000289/0000904454-19-000289-index.htm
2019-02-05Adam WoodrowVP & Chief Commercial OfficerSell3,331.006.7722,550.87144,694.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000182/0000904454-19-000182-index.htm
2019-02-01Adam WoodrowVP & Chief Commercial OfficerBuy16,250.00148,025.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000153/0000904454-19-000153-index.htm
2019-02-26William M. HaskelSr. VP, Sec. & General CounselBuy37,000.00149,220.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000278/0000904454-19-000278-index.htm
2019-04-05Douglas W. PaganChief Financial OfficerSell19,500.00151,557.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000351/0000904454-19-000351-index.htm
2019-12-12William M. HaskelSr. VP, Sec. & General CounselSell2,864.003.108,878.40158,356.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000745/0000904454-19-000745-index.htm
2019-10-04William M. HaskelSr. VP, Sec. & General CounselBuy12,000.00161,220.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000676/0000904454-19-000676-index.htm
2019-02-26Douglas W. PaganChief Financial OfficerBuy37,000.00171,057.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000284/0000904454-19-000284-index.htm
2019-02-26Jeffrey SteinDirectorBuy7,500.0017,625.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000291/0000904454-19-000291-index.htm
2020-05-12William M. HaskelSr. VP, Sec. & General CounselSell4,666.004.7522,163.50198,690.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000365/0000904454-20-000365-index.htm
2020-02-19William M. HaskelSr. VP, Sec. & General CounselBuy45,000.00203,356.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000230/0000904454-20-000230-index.htm
2019-02-26Adam WoodrowVP & Chief Commercial OfficerBuy60,000.00204,694.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000293/0000904454-19-000293-index.htm
2019-12-12Adam WoodrowPresident & Chief CommercialSell4,401.003.1013,643.10207,971.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000739/0000904454-19-000739-index.htm
2019-02-26Kristine PetersonDirectorBuy7,500.0021,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000287/0000904454-19-000287-index.htm
2020-02-19Thomas John DietzDirectorBuy9,000.0021,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000238/0000904454-20-000238-index.htm
2019-02-26Timothy R FransonDirectorBuy7,500.0021,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000276/0000904454-19-000276-index.htm
2019-10-08Adam WoodrowPresident & Chief CommercialSell5,322.003.8220,330.04212,372.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000680/0000904454-19-000680-index.htm
2018-10-02MICHAEL BIGHAMChairman and CEOBuy36,250.00213,480.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000648/0000904454-18-000648-index.htm
2019-10-04Adam WoodrowPresident & Chief CommercialBuy13,000.00217,694.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000680/0000904454-19-000680-index.htm
2020-02-19Robert S RadieDirectorBuy9,000.0023,250.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000242/0000904454-20-000242-index.htm
2018-10-02Evan LohPresident, COO and CMOBuy32,500.00235,286.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000642/0000904454-18-000642-index.htm
2018-12-12MICHAEL BIGHAMChairman and CEOSell8,400.006.7656,784.00256,467.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000789/0000904454-18-000789-index.htm
2018-10-03MICHAEL BIGHAMChairman and CEOSell16,313.009.82160,193.66257,167.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000648/0000904454-18-000648-index.htm
2019-02-26Rolf K HoffmannDirectorBuy7,500.0026,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000280/0000904454-19-000280-index.htm
2018-10-15MICHAEL BIGHAMChairman and CEOSell6,300.008.9656,448.00264,867.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000669/0000904454-18-000669-index.htm
2020-02-19Jeffrey SteinDirectorBuy9,000.0026,625.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000240/0000904454-20-000240-index.htm
2020-05-12Adam WoodrowPresident & Chief CommercialSell4,798.004.7522,790.50270,673.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000361/0000904454-20-000361-index.htm
2018-10-12MICHAEL BIGHAMChairman and CEOBuy14,000.00271,167.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000669/0000904454-18-000669-index.htm
2019-02-01MICHAEL BIGHAMChairman and CEOBuy35,000.00271,417.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000147/0000904454-19-000147-index.htm
2018-10-02MICHAEL BIGHAMChairman and CEOBuy60,000.00273,480.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000648/0000904454-18-000648-index.htm
2020-02-19Adam WoodrowPresident & Chief CommercialBuy67,500.00275,471.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000224/0000904454-20-000224-index.htm
2018-12-13Evan LohPresident, COO and CMOSell6,000.006.2737,620.00277,700.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000783/0000904454-18-000783-index.htm
2018-10-03Evan LohPresident, COO and CMOSell8,861.009.8287,015.02281,425.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000642/0000904454-18-000642-index.htm
2018-12-12Evan LohPresident, COO and CMOSell5,525.006.7637,349.00283,700.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000783/0000904454-18-000783-index.htm
2018-10-15Evan LohPresident, COO and CMOSell5,200.008.9646,592.00289,225.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000663/0000904454-18-000663-index.htm
2018-10-02Evan LohPresident, COO and CMOBuy55,000.00290,286.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000642/0000904454-18-000642-index.htm
2018-10-12Evan LohPresident, COO and CMOBuy13,000.00294,425.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000663/0000904454-18-000663-index.htm
2020-02-19Kristine PetersonDirectorBuy9,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000236/0000904454-20-000236-index.htm
2020-02-19Timothy R FransonDirectorBuy9,000.0030,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000244/0000904454-20-000244-index.htm
2019-02-01Evan LohPresident, COO and CMOBuy32,500.00310,200.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000149/0000904454-19-000149-index.htm
2020-02-19Rolf K HoffmannDirectorBuy9,000.0035,000.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000234/0000904454-20-000234-index.htm
2019-02-26MICHAEL BIGHAMChairman and CEOBuy120,000.00391,417.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000272/0000904454-19-000272-index.htm
2019-10-03Evan LohCEOSell16,265.003.9864,734.70413,935.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000669/0000904454-19-000669-index.htm
2019-12-12Evan LohCEOSell14,514.003.1044,993.40417,603.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000741/0000904454-19-000741-index.htm
2019-10-04MICHAEL BIGHAMDirectorBuy28,000.00419,417.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000672/0000904454-19-000672-index.htm
2019-02-26Evan LohPresident, COO and CMOBuy120,000.00430,200.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000282/0000904454-19-000282-index.htm
2019-10-08Evan LohCEOSell7,818.003.8229,864.76432,117.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000678/0000904454-19-000678-index.htm
2019-10-04Evan LohCEOBuy26,000.00439,935.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000678/0000904454-19-000678-index.htm
2019-02-15Thomas John DietzDirectorSell3,000.007.1421,420.004,500.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000260/0000904454-19-000260-index.htm
2020-05-12MICHAEL BIGHAMExec. Chairman of the BoardSell12,250.004.6857,330.00542,167.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000357/0000904454-20-000357-index.htm
2020-05-12Evan LohCEOSell9,595.004.7545,576.25552,008.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000359/0000904454-20-000359-index.htm
2020-02-19MICHAEL BIGHAMDirectorBuy135,000.00554,417.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000232/0000904454-20-000232-index.htm
2020-02-19Evan LohCEOBuy144,000.00561,603.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000226/0000904454-20-000226-index.htm
2020-10-29Evan LohCEOBuy39,479.004.30169,759.70591,487.00https://www.sec.gov/Archives/edgar/data/1178711/000090445420000693/0000904454-20-000693-index.htm
2019-02-15Robert S RadieDirectorSell3,750.007.1426,775.006,750.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000258/0000904454-19-000258-index.htm
2019-04-05Douglas W. PaganChief Financial OfficerSell16,250.0070,807.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000351/0000904454-19-000351-index.htm
2018-12-21Thomas John DietzDirectorSell9,330.005.0146,743.307,500.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000798/0000904454-18-000798-index.htm
2018-10-02William M. HaskelSr. VP, Sec. & General CounselBuy17,500.0079,774.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000650/0000904454-18-000650-index.htm
2019-04-05Douglas W. PaganChief Financial OfficerSell27,500.0087,057.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000351/0000904454-19-000351-index.htm
2019-10-03Randall B. BrennerChief Development & RegulatorySell7,674.003.9830,542.5291,338.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000667/0000904454-19-000667-index.htm
2019-12-12Randall B. BrennerChief Development & RegulatorySell6,278.003.1019,461.8092,011.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000743/0000904454-19-000743-index.htm
2019-10-08Randall B. BrennerChief Development & RegulatorySell5,049.003.8219,287.1898,289.00https://www.sec.gov/Archives/edgar/data/1178711/000090445419000674/0000904454-19-000674-index.htm
2018-12-13William M. HaskelSr. VP, Sec. & General CounselSell1,000.006.256,250.0098,551.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000785/0000904454-18-000785-index.htm
2018-10-03William M. HaskelSr. VP, Sec. & General CounselSell5,860.009.8257,545.2098,914.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000650/0000904454-18-000650-index.htm
2018-12-12William M. HaskelSr. VP, Sec. & General CounselSell3,132.006.7621,172.3299,551.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000785/0000904454-18-000785-index.htm
2018-10-02Douglas W. PaganChief Financial OfficerBuy22,500.0099,583.00https://www.sec.gov/Archives/edgar/data/1178711/000090445418000644/0000904454-18-000644-index.htm